Hercules Capital Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF93.30 | CHF105.00 | 15.35% | 9 | CHF190.37B |
| SAN | Sanofi | Outperform |
16
|
90.56€ | 102.80€ | 20.91% | 9 | 113.21€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.55 | $58.15 | 21.21% | 10 | $90.31B |
| MRK | Merck KGaA | Outperform |
18
|
165.85€ | 190.06€ | 7.33% | 4 | 72.11€B |
| BIIB | Biogen | Outperform |
10
|
$235.32 | $299.62 | 22.60% | 13 | $34.26B |
| BAYN | Bayer | Hold |
5
|
29.33€ | 45.15€ | 2.28% | 4 | 28.81€B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.78 | $11.59 | 1.31% | 9 | $19.01B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.07k | kr2.71k | 27.85% | 14 | kr133.38B |
| ARCC | Ares Capital | Outperform |
14
|
$21.17 | $21.50 | 3.92% | 14 | $12.71B |
| FSK | FS KKR Capital | Hold |
13
|
$20.01 | $21.55 | -0.05% | 10 | $5.56B |
| MAIN | Main Street Capital | Hold |
12
|
$49.31 | $44.17 | -0.63% | 6 | $4.31B |
| ALKS | Alkermes | Outperform |
10
|
$24.14 | $33.27 | 32.56% | 3 | $4.11B |
| GBDC | Golub Capital BDC | Outperform |
14
|
$16.30 | $15.90 | 4.29% | 5 | $2.82B |
| PSEC | Prospect Capital | Underperform |
12
|
$5.66 | $5.50 | -2.83% | 0 | $2.16B |
| TSLX | Sixth Street Specialty Lending | Outperform |
14
|
$21.43 | $21.91 | 4.99% | 10 | $2.00B |
| GSBD | Goldman Sachs BDC | Hold |
12
|
$15.64 | $14.50 | -4.09% | 5 | $1.76B |
| OCSL | Oaktree Specialty Lending Corp | Outperform |
14
|
$19.24 | $7.79 | 3.95% | 6 | $1.51B |
| NMFC | New Mountain Finance | Outperform |
14
|
$12.58 | $13.14 | 3.34% | 6 | $1.35B |
| CSWC | Capital Southwest | Outperform |
15
|
$26.39 | $22.81 | -1.48% | 6 | $1.17B |
| BBDC | Barings BDC | Outperform |
16
|
$9.77 | $9.86 | 4.91% | 6 | $1.02B |
| MFIC | MidCap Financial Investment | Outperform |
13
|
$15.71 | $13.86 | -2.93% | 7 | $1.00B |
| TCPC | BlackRock TCP Capital | Hold |
14
|
$10.70 | $12.50 | -4.21% | 6 | $891.86M |
| CGBD | Carlyle Secured Lending | Hold |
14
|
$17.95 | $15.42 | -5.29% | 6 | $884.85M |
| SLRC | SLR Investment | Hold |
12
|
$16.08 | $15.50 | -0.50% | 9 | $852.14M |
| PFLT | PennantPark Floating Rate Capi... | Hold |
12
|
$11.35 | $11.60 | 1.32% | 4 | $714.27M |
| FDUS | Fidus Investment | Outperform |
14
|
$19.80 | $20.92 | 6.06% | 6 | $621.82M |
| GAIN | Gladstone Investment | Hold |
14
|
$14.21 | $14.60 | -1.48% | 5 | $508.20M |
| GLAD | Gladstone Capital | Hold |
12
|
$22.31 | $10.50 | -1.39% | 4 | $473.59M |
| PNNT | PennantPark Investment | Hold |
13
|
$7.33 | $7.09 | -4.50% | 5 | $471.57M |
| HRZN | Horizon Technology Finance | Hold |
12
|
$11.74 | $11.59 | -14.82% | 7 | $400.99M |
| TPVG | TriplePoint Venture Growth BDC | Hold |
12
|
$9.15 | $10.66 | 3.83% | 8 | $353.25M |
| SCM | Stellus Capital Investment | Hold |
14
|
$14.19 | $14.08 | -1.34% | 5 | $339.21M |
| SAR | Saratoga Investment | Outperform |
4
|
$23.47 | $27.61 | 6.52% | 4 | $323.72M |
| NEWT | NewtekOne | Hold |
16
|
$13.89 | $15.63 | -6.41% | 2 | $284.07M |
| BKCC | BlackRock Capital Investment | - |
12
|
$3.80 | $3.50 | -100.00% | 2 | $275.77M |
| OXSQ | Oxford Square Capital | Hold |
13
|
$3.22 | $4.75 | -40.06% | 0 | $191.55M |
| PTMN | Portman Ridge Finance | Outperform |
13
|
$20.07 | $21.50 | -0.35% | 2 | $180.93M |
| MFIN | Medallion Financial | Outperform |
11
|
$8.13 | $11.00 | 47.60% | 0 | $164.73M |
| MRCC | Monroe Capital | Hold |
14
|
$7.28 | $8.67 | 23.63% | 5 | $156.86M |
| OFS | OFS Capital | Hold |
16
|
$9.63 | $10.75 | -6.54% | 2 | $129.29M |
| PFX | PhenixFIN | Hold |
8
|
$46.00 | $35.00 | -67.09% | 0 | $89.37M |
| LRFC | Logan Ridge Finance | Buy |
10
|
$22.47 | $27.00 | 11.26% | 1 | $58.93M |
| TURN | 180 Degree Capital | - |
-3
|
$4.06 | $12.00 | -100.00% | 0 | $38.50M |